Biocon Limited has informed the Exchange regarding a press release dated December 28, 2020, titled "Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US".
Biocon Limited has informed the Exchange regarding a press release dated December 28, 2020, titled "Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US".